During the past decade, Univerzitna nemocnica Bratislava, Nemocnica Ruzinov conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Univerzitna nemocnica Bratislava, Nemocnica Ruzinov" #1 sponsor was "Celgene" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Takeda" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "Oxurion" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univerzitna nemocnica Bratislava, Nemocnica Ruzinov" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Univerzitna nemocnica Bratislava, Nemocnica Ruzinov" are "Crohn Disease" (4 trials), "Colitis, Ulcerative" (3 trials), "Crohn's Disease" (2 trials), "Diabetes Mellitus" (2 trials) and "Diabetic Retinopathy" (2 trials). Many other conditions were trialed in "Univerzitna nemocnica Bratislava, Nemocnica Ruzinov" in a lesser frequency.

Most popular intervention types in "Univerzitna nemocnica Bratislava, Nemocnica Ruzinov" are "Drug" (18 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ocrelizumab" (3 trials), "Ozanimod" (3 trials), "Avelumab" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Univerzitna nemocnica Bratislava, Nemocnica Ruzinov" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Univerzitna nemocnica Bratislava, Nemocnica Ruzinov". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Univerzitna nemocnica Bratislava, Nemocnica Ruzinov, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Univerzitna nemocnica Bratislava, Nemocnica Ruzinov, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".